Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Treatment Algorithm : Diabetes' returned 40 results - Page 1 of 2   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Treatment Algorithms: Type 2 Diabetes - Novel classes drive fragmentation of treatment choices in type 2 diabetes   Datamonitor, July 2011, Pages: 92 - Identify opportunities to consolidate patient share in the widely fragmented diabetes treatment algorithm. - Gain insight into physicians’ perceptions on trends in use of key antidiabetic classes The Diabetes Market Outlook to 2016   Business Insights, May 2011, Pages: 132 ? Types of diabetes Type 2 diabetes Gestational diabetes mellitus Impaired glucose tolerance Diabetic complications Epidemiology Diagnosis How is diabetes measured? Treatment algorithm Global Turn of The Decade: Novel Glp-1’s To Emerge as the New Leader in Diabetes Class   MP Advisors, Aug 2011 opportunity available in the diabetes market. Due to compliance issues and long term safety concerns, currently the use of GLP-1 is limited prior to insulin and after oral treatment options are exhausted Ophthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy Market   GBI Research, Oct 2011, Pages: 156 Market - Diabetic Retinopathy 94 10.1 Introduction 94 10.2 Global Market Forecasts 94 10.3 Annual Cost of Treatment 96 10.4 Branded and Generic Market Share 97 10.5 Treatment Flow Algorithm 98 10.6 Treatment Usage Hot Topics in Type 2 Diabetes: Physician Perceptions of Insulin - Physician survey provides insights into insulin usage and needs   Datamonitor, June 2011, Pages: 54 markets. - Identify unmet needs in insulin therapy and opportunities in the type 2 diabetes treatment algorithm. Executive Summary Strategic scoping and focus Datamonitor key findings Diabetes Metabolic Disorders Therapeutics Market to 2017 - Patent Expiry of Lipitor in 2011 will Negatively Impact Dyslipidemia Market Value   GBI Research, Oct 2011, Pages: 169 , including diabetes, obesity and dyslipidemia. The report also provides the share of generics in global metabolic diseases as well as in each indication market. It also provides the treatment algorithm flow Stakeholder Opinions: Diabetic Renal Disease   Datamonitor, Nov 2008, Pages: 88 with serious complications (e.g. end-stage renal disease, acute myocardial infarction, amputation), 2007 Figure 12: Treatment algorithm for type 2 diabetes, recommended by the 2006 ADA/EASD clinical practice Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia - Growth Opportunities in Fragmented Markets   Datamonitor, Dec 2008, Pages: 115 , GCC 14 Figure 2: Top 10 countries in prevalence of diabetes (20-79 age group) 24 Figure 3: Current prevalence of diabetes and forecasts for 2025 26 Figure 4: Treatment algorithm for type 2 diabetes The Global Diabetes Market: Therapeutics, Diagnostics and Complications   Arrowhead Publishers, Aug 2006, Pages: 218 Market US$6bn (2005) Figure 3.1 Glycosylated hemoglobin levels versus blood glucose Figure 7.1 Schematic of Glycaemic Control in Non-Diabetics and Diabetics Figure 7.2 Treatment Algorithm for Type2 Diabetics Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010   Life Science Intelligence, Inc., Jan 2011 regulation therapy for type 2 diabetes - Medical device for the symptomatic treatment of rhinitis (allergies) - Cardiac mapping system that is non-invasive, maps the entire heart in one beat, and provides 71st Scientific sessions of American Diabetes Association 2011 - Post-Conference Review and Analysis   GlobalData, July 2011, Pages: 32 . The five day conference include a demonstration of improvements in both treatment options for diabetes and understanding of the mechanisms behind the disease. This report, entitled “71st Scientific sessions Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009   Life Science Intelligence, Inc., Dec 2009, Pages: 1763 on an exclusive intellectual property platform for both fusion and non-fusion products - Non-invasive modality for the treatment of insulin resistance/diabetic neuropathy - Non-invasive robotic radiosurgery Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitors bring added benefits to diabetes therapy.   Datamonitor, Dec 2010, Pages: 416 of SGLT-2 inhibitors will provide another option in a crowded treatment algorithm for type 2 diabetes. Reasons to Purchase -Quantify the sales of pipeline drugs in the non-insulin antidiabetic Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers   Datamonitor, Dec 2010, Pages: 416 treatment algorithm for type 2 diabetes. Key reasons to purchase this research - Quantify the sales of pipeline drugs in the non-insulin antidiabetic market. - Identify licensing opportunities based Pain Therapeutics - Drugs, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 532 of chemotherapy-induced pain Morton’s neuroma Management of peripheral diabetic neuropathy Postherpetic neuralgia Complex regional pain syndrome An algorithm for the management of peripheral neuropathic pain The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights   Arrowhead Publishers, Oct 2010, Pages: 385 Incidence Forecast in the Seven Major Markets, 2008-2020 Figure 19: Treatment Algorithm for Fibromyalgia Figure 20: Arthritis Incidence Forecast in the Seven Major Markets, 2008-2020 Figure 21: Arthritis New Approaches to Gaining Market Access for Pharmaceuticals: Pricing & Reimbursement, Policy Development, and the Role of HTAs   Business Insights, Oct 2010, Pages: 110 . Market access is becoming more challenging for new pharmaceuticals, especially expensive treatments that drive up drug spending. More emphasis is being placed on value for money, with economic evaluation becoming The Foot in Diabetes, 4th Edition   John Wiley and Sons Ltd, May 2006, Pages: 464 Staphylococcus aureus (Anthony R. Berendt and Benjamin A. Lipsky). 15 Dressings: Is There an Evidence Base? (Ann Knowles). 16 New and Alternative Treatments for the Diabetic Foot: Stem Cells and Gene Transfer Valuing Pharmaceutical Innovation: Pricing and Reimbursement for Innovative Therapies   Business Insights, Aug 2008, Pages: 121 challenges of recently launched innovative therapies 70 Summary 70 Introduction 71 New market innovations 71 Gardasil (human papilloma virus vaccine): changing the treatment algorithm 71 Lysosomal storage RNAi - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 485 siRNA for Duchenne muscular dystrophy siRNA for dystonia RNAi in ophthalmology Age related macular degeneration Current treatment of AMD RNAi-based treatments for AMD Diabetic retinopathy Results:  First -   Prev -   1 -   2 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network